Abstract #1512

Early cancer signs detected by glucoCEST

Francisco Torrealdea¹, Marilena Rega¹, Sebastian Brandner¹, David Thomas¹, and Xavier Golay¹

¹Brain Repair & Rehabilitation, UCL Institute of Neurology, London, United Kingdom

In this work, the feasibility of using glucoCEST as a tool for early detection of primary brain tumours is explored. Mice bearing xenograft glioblastoma tumours were scanned longitudinally using a glucoCEST protocol. The results suggest the intriguing possibility that glucoCEST contrast may be able to detect the presence of cancer at very early stage.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.